# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026386
Filing Date
2024-08-13
Accepted
2024-08-13 16:11:02
Documents
95
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | nby20240630_10q.htm iXBRL | 10-Q | 2323195
2 | EXHIBIT 31.1 | ex_709225.htm | EX-31.1 | 7900
3 | EXHIBIT 31.2 | ex_709226.htm | EX-31.2 | 8257
4 | EXHIBIT 32.1 | ex_709227.htm | EX-32.1 | 3978
5 | EXHIBIT 32.2 | ex_709228.htm | EX-32.2 | 3816
| Complete submission text file | 0001437749-24-026386.txt |  | 12416908

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20240630.xsd | EX-101.SCH | 108257
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20240630_def.xml | EX-101.DEF | 701646
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20240630_lab.xml | EX-101.LAB | 547711
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20240630_pre.xml | EX-101.PRE | 745074
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nby-20240630_cal.xml | EX-101.CAL | 42892
98 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20240630_10q_htm.xml | XML | 2546213

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 241201538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)